| Literature DB >> 34399005 |
Alexios G Stamoulis1, Peng Geng2, Michael A Schmidt2, Martin D Eastgate2, Alina Borovika2, Kenneth J Fraunhoffer2, Shannon S Stahl1.
Abstract
The 1,4-diacyloxylation of 1,3-cyclohexadiene (CHD) affords valuable stereochemically defined scaffolds for natural product and pharmaceutical synthesis. Existing cis-selective diacyloxylation protocols require superstoichiometric quantities of benzoquinone (BQ) or MnO2 , which limit process sustainability and large-scale application. In this report, reaction development and mechanistic studies are described that overcome these limitations by pairing catalytic BQ with tert-butyl hydroperoxide as the stoichiometric oxidant. Catalytic quantities of bromide enable a switch from trans to cis diastereoselectivity. A catalyst with a 1:2 Pd:Br ratio supports high cis selectivity while retaining good rate and product yield. Further studies enable replacement of BQ with hydroquinone (HQ) as a source of cocatalyst, avoiding the handling of volatile and toxic BQ in large-scale applications.Entities:
Keywords: difunctionalization; homogeneous catalysis; oxidation; palladium; synthetic methods
Mesh:
Substances:
Year: 2021 PMID: 34399005 PMCID: PMC8511170 DOI: 10.1002/anie.202108499
Source DB: PubMed Journal: Angew Chem Int Ed Engl ISSN: 1433-7851 Impact factor: 16.823